These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 4923653

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. L-dopa in the treatment of Parkinsonism; a preliminary appraisal.
    Stellar S, Mandell S, Waltz JM, Cooper IS.
    J Neurosurg; 1970 Mar; 32(3):275-80. PubMed ID: 5416909
    [No Abstract] [Full Text] [Related]

  • 24. Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa.
    Godwin-Austen RB, Bergmann S, Frears CC.
    Br Med J; 1971 Nov 27; 4(5786):522-4. PubMed ID: 4942463
    [Abstract] [Full Text] [Related]

  • 25. L-Dopa in the treatment of parkinsonism.
    Calne DB.
    Clin Pharmacol Ther; 1970 Nov 27; 11(6):789-801. PubMed ID: 4921292
    [No Abstract] [Full Text] [Related]

  • 26. Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism.
    Mones RJ, Elizan TS, Siegel GJ.
    J Neurol Neurosurg Psychiatry; 1971 Dec 27; 34(6):668-73. PubMed ID: 5158780
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University).
    Gutmann L, Martin JD, Gutrecht JA.
    W V Med J; 1970 Apr 27; 66(4):109-11. PubMed ID: 5264660
    [No Abstract] [Full Text] [Related]

  • 30. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W.
    Wien Klin Wochenschr; 1971 Apr 02; 83(13):221-7. PubMed ID: 4254333
    [No Abstract] [Full Text] [Related]

  • 31. [Indications and results of monoamine treatment in parkinsonian syndromes].
    Boudin G, Pépin B, Guillard A, Fabiani JM, Haguenau M.
    Rev Neurol (Paris); 1972 Jul 02; 127(1):79-97. PubMed ID: 4520464
    [No Abstract] [Full Text] [Related]

  • 32. Long-term results of ventrolateral thalamotomy for patients with Parkinson's disease.
    Moriyama E, Beck H, Miyamoto T.
    Neurol Med Chir (Tokyo); 1999 May 02; 39(5):350-6; discussion 356-7. PubMed ID: 10481437
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Advances in the treatment of parkinsonism].
    Dowzenko A.
    Neurol Neurochir Pol; 1972 May 02; 6(2):275-80. PubMed ID: 4555308
    [No Abstract] [Full Text] [Related]

  • 35. L-dopa therapy in Parkinson's disease.
    Lipman IJ.
    Va Med Mon (1918); 1971 May 02; 98(5):242-8. PubMed ID: 4931138
    [No Abstract] [Full Text] [Related]

  • 36. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J, Dupont E, Mikkelsen B.
    Ugeskr Laeger; 1971 Nov 26; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.